On Monday, Shares of Cobalt International Energy, Inc. (NYSE:CIE), added 3.64% and closed at $1.14 in the last trading session. The last trading range of the stock ranges between $.12 and $1.21. The company’s Market capitalization is $42570 million with the total Outstanding Shares of 410.05 million. Cobalt International Energy, Inc., through its auxiliaries, operates as an oil and gas exploration and production company mainly in the deepwater U.S. Gulf of Mexico. The company holds interests in the North Platte, Shenandoah, Anchor, and Heidelberg fields located in the U.S. Gulf of Mexico; and the Diaba block located offshore Gabon. As of December 31, 2015, it had net proved undeveloped reserves of 5.6 million barrels (MMBbls) of oil; 0.3 MMBbls of natural gas liquids; and 1.8 billion cubic feet of natural gas.
Johnson & Johnson (NYSE:JNJ), jumped 0.47% and closed at $119.80 in the last trading session. The last trading range of the stock ranges between $119.35 and $120.20. The company’s Market capitalization is $329.11 Billion with the total Outstanding Shares of 2.74 billion. During the 52-week trading session the minimum price at which share price traded, registered at $94.12 and reached to max level of $126.07. Johnson & Johnson, together with its auxiliaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSONS brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSONS Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; womens health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, counting adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, counting acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses.
On the otherhand AbbVie Inc (NYSE:ABBV), jumped 0.60% and closed at $63.31 in the last trading session. The last trading range of the stock ranges between $62.92 and $63.66. The company’s Market capitalization is $103.27 Billion with the total Outstanding Shares of 1.63 million. During the 52-week trading session the minimum price at which share price traded, registered at $45.45 and reached to max level of $68.12. AbbVie (ABBV) will declare its third-quarter 2016 financial results on Friday, October 28, 2016, before the market opens.
AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern). It will be accessible through AbbVie’s Shareholder Relations website.